Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayako Shimada

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Vaccines|July 29, 2023
Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to <i>Onchocerca volvulus</i> in Mice and Non-Human PrimatesNathan M Ryan, Jessica A Hess, Erica J Robertson, et al.
Nature Communications|March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
JCO Precision Oncology|September 30, 2021
Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice NeedsJessica Russo, Carey McDougall, Nicholas Bowler, et al.
JAMA Oncology|December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical TrialAnn H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2021
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell CarcinomaAdam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Vaccines|July 29, 2023
Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to <i>Onchocerca volvulus</i> in Mice and Non-Human PrimatesNathan M Ryan, Jessica A Hess, Erica J Robertson, et al.
Nature Communications|March 17, 2022
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaClaudia Capparelli, Timothy J Purwin, McKenna Glasheen, et al.
JCO Precision Oncology|September 30, 2021
Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice NeedsJessica Russo, Carey McDougall, Nicholas Bowler, et al.
JAMA Oncology|December 12, 2024
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical TrialAnn H Partridge, Terry Hyslop, Shoshana M Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2021
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell CarcinomaAdam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Pageof 7